SII CEO Adar Poonawalla

Photo: Hindustan Times

SII To Launch Covavax For Children In Mid 2022: Adar Poonawalla

The Serum Institute of India CEO Adar Poonawalla announced to launch COVID-19 vaccine against children (3+). Addressing an event at SII, on December 14, Poonawalla said, Covavax is an Indian made version of the US-based Novavax. It is currently under trial and is showing excellent results on children. If successful, Covavax will be launched by mid-2022 in India, protecting kids against the COVID-19 virus. 

Tue, 14 Dec 2021 - 07:09 PM / by Varsha Joshi

Tags: SII, Adar Poonawalla, Covavax, children, Covid-19

Courtesy: The Siasat Daily